Venus Remedies Limited
₹1,616.30
-0.49%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Low debt: debt-to-equity of 0.02.
- Return on equity is healthy at 16.8%.
- Return on capital employed is healthy at 21.7%.
- Net profit margin is 13.4%.
- Profit has compounded about 22% a year over five years.
- Pays a dividend (yield about 0.62%).
- Promoters hold a sizeable stake (41.76%).
!Watch-points
No notable watch-points flagged by the automated checks.
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreSafe zone
4.05
In Altman’s original study, companies in this range showed a low incidence of financial distress.
Computed without the working-capital term (current-asset split not available for this stock).
Piotroski F-ScoreModerate
6 / 7
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 7 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap₹ 2,163 Cr
Current Price₹ 1,616.30
High / Low₹ 2,044.30 / 424.00
Stock P/E18.586708
Book Value₹ 497.00
Dividend Yield0%
ROCE21.70%
ROE16.80%
Face Value₹ 10.00
Debt to Equity0.02
PEG Ratio0.33
EV / EBITDA12.56
Industry PE35.70
P/B Ratio3.254798
EPS₹ 76.90
Debt₹ 12 Cr
PAT Margin13.38%
Cash PAT₹ 129 Cr
ICR—
Promoter Holding41.76%
FII Holding2.92%
DII Holding0.89%
Public Holding54.44%
Note on calculated ratios: where a value is not published in the source data, we compute it from the reported financials — Debt to Equity = total borrowings ÷ (equity capital + reserves); EV / EBITDA = (market cap + debt − cash) ÷ (operating profit + depreciation); PEG = P/E ÷ 3-year profit growth %. These may differ slightly from other sources that use different periods or TTM figures. Current Price, Market Cap and P/E reflect the live quote (cached 15 min).
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity